相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder
Livia Maria Bolsoni et al.
PSYCHOPHARMACOLOGY (2022)
UK Medical Cannabis registry: an analysis of clinical outcomes of medicinal cannabis therapy for chronic pain conditions
Michael Harris et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2022)
UK Medical Cannabis Registry: an analysis of clinical outcomes of medicinal cannabis therapy for generalized anxiety disorder
Mehmet Ergisi et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2022)
Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain on Long-Term High Dose Opioid Analgesia: A Pilot Study
Yvonne Bonomo et al.
PAIN AND THERAPY (2022)
Drug-Drug Interaction Between Orally Administered Hydrocodone-Acetaminophen and Inhalation of Cannabis Smoke: A Case Report
Ross Jason Bindler et al.
HOSPITAL PHARMACY (2022)
Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report
Cathy Davies et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2022)
Mood, sleep and pain comorbidity outcomes in cannabis dependent patients: Findings from a nabiximols versus placebo randomised controlled trial
Mark Montebello et al.
DRUG AND ALCOHOL DEPENDENCE (2022)
Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters
Jose A. Crippa et al.
BRAZILIAN JOURNAL OF PSYCHIATRY (2022)
The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event
Livia Maria Bolsoni et al.
BRAZILIAN JOURNAL OF PSYCHIATRY (2022)
A Double-Blind, Randomized, Placebo-Controlled Test of the Effects of Cannabidiol on Experiences of Test Anxiety Among College Students
Taylor B. Stanley et al.
CANNABIS AND CANNABINOID RESEARCH (2022)
UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomes
Devaki Nimalan et al.
JOURNAL OF CANNABIS RESEARCH (2022)
Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis
Aisling O'Neill et al.
PSYCHOLOGICAL MEDICINE (2021)
Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments
Luke A. McGuinness et al.
RESEARCH SYNTHESIS METHODS (2021)
Cannabis use and sleep: Expectations, outcomes, and the role of age
Evan A. Winiger et al.
ADDICTIVE BEHAVIORS (2021)
Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
Carolina de Meneses-Gaya et al.
BRAZILIAN JOURNAL OF PSYCHIATRY (2021)
Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review
Corneliu N. Stanciu et al.
PSYCHIATRIC SERVICES (2021)
Acute objective and subjective intoxication effects of legal-market high potency THC-dominant versus CBD-dominant cannabis concentrates
M. L. Drennan et al.
SCIENTIFIC REPORTS (2021)
Cannabidiol as a Treatment for Mental Health Outcomes Among Health Care Workers During the Coronavirus Disease Pandemic
Julia Cozar Pacheco et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2021)
Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder
Carlos M. O. de Almeida et al.
MOVEMENT DISORDERS (2021)
The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial
Marcel O. Bonn-Miller et al.
PLOS ONE (2021)
Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study
Orrin Devinsky et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
An Observational, Longitudinal Study of Cognition in Medical Cannabis Patients over the Course of 12 Months of Treatment: Preliminary Results
Kelly A. Sagar et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2021)
Efficacy and Safety of Cannabidiol Plus Standard Care vs Standard Care Alone for the Treatment of Emotional Exhaustion and Burnout Among Frontline Health Care Workers During the COVID-19 Pandemic A Randomized Clinical Trial
Jose Alexandre S. Crippa et al.
JAMA NETWORK OPEN (2021)
Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process
Arun Bhaskar et al.
JOURNAL OF CANNABIS RESEARCH (2021)
Evaluating the Suitability and Potential Efficiency of Cannabis sativa Oil for Patients with Primary Burning Mouth Syndrome: A Prospective, Open-Label, Single-Arm Pilot Study
Alessio Gambino et al.
PAIN MEDICINE (2021)
Blunted highs: Pharmacodynamic and behavioral models of cannabis tolerance
J. G. Ramaekers et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson's disease
Stephanie Martins de Faria et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2020)
Use of cannabidiol in anxiety and anxiety-related disorders
Jessica W. Skelley et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2020)
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis
E. Appiah-Kusi et al.
PSYCHOPHARMACOLOGY (2020)
Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study
Reilly R. Kayser et al.
DEPRESSION AND ANXIETY (2020)
Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies
Anastasia S. Suraev et al.
SLEEP MEDICINE REVIEWS (2020)
Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users
Tory R. Spindle et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions
Marian Newton et al.
JOURNAL OF THE AMERICAN PSYCHIATRIC NURSES ASSOCIATION (2020)
Long-term assessment of the cognitive effects of nabiximols in patients with multiple sclerosis: A pilot study
Giulia Alessandria et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2020)
Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance A Randomized Clinical Trial
Thomas R. Arkell et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients
Joshua Aviram et al.
PHARMACEUTICALS (2020)
Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial
Yasmin L. Hurd et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
Thomas R. Arkell et al.
PSYCHOPHARMACOLOGY (2019)
Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms
David J. Casarett et al.
JOURNAL OF PALLIATIVE MEDICINE (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
Ila M. Linares et al.
BRAZILIAN JOURNAL OF PSYCHIATRY (2019)
A meta-analysis of the crash risk of cannabis-positive drivers in culpability studies-Avoiding interpretational bias
Ole Rogeberg
ACCIDENT ANALYSIS AND PREVENTION (2019)
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
Marta Di Forti et al.
LANCET PSYCHIATRY (2019)
Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivity
Oliver Grimm et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2018)
Driving Under the Influence of Cannabis An Increasing Public Health Concern
Johannes G. Ramaekers
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
A naturalistic examination of the perceived effects of cannabis on negative affect
Carrie Cuttler et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling
Manoela V. Fogaca et al.
NEUROPHARMACOLOGY (2018)
No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
Ila M. P. Linares et al.
FRONTIERS IN PHARMACOLOGY (2018)
Hyperarousal and sleep reactivity in insomnia: current insights
David A. Kalmbach et al.
NATURE AND SCIENCE OF SLEEP (2018)
Therapeutic Effects of Prolonged Cannabidiol Treatment on Psychological Symptoms and Cognitive Function in Regular Cannabis Users: A Pragmatic Open-Label Clinical Trial
Nadia Solowij et al.
CANNABIS AND CANNABINOID RESEARCH (2018)
Prolonged Cannabidiol Treatment Effects on Hippocampal Subfield Volumes in Current Cannabis Users
Camilla Beale et al.
CANNABIS AND CANNABINOID RESEARCH (2018)
Cannabis, Cannabinoids, and Sleep: a Review of the Literature
Kimberly A. Babson et al.
CURRENT PSYCHIATRY REPORTS (2017)
Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
Antonio W. Zuardi et al.
Frontiers in Pharmacology (2017)
PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement
Jessie McGowan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Association Between Continued Cannabis Use and Risk of Relapse in First-Episode Psychosis A Quasi-Experimental Investigation Within an Observational Study
Tabea Schoeler et al.
JAMA PSYCHIATRY (2016)
A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy
Michelle Sexton et al.
CANNABIS AND CANNABINOID RESEARCH (2016)
Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study
Tabea Schoeler et al.
LANCET PSYCHIATRY (2016)
Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes
Ethan B. Russo
CANNABIS AND CANNABINOID RESEARCH (2016)
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
Chandni Hindocha et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety
J. Megan Gray et al.
JOURNAL OF NEUROSCIENCE (2015)
Cannabidiol as a Potential Treatment for Anxiety Disorders
Esther M. Blessing et al.
NEUROTHERAPEUTICS (2015)
Interactions between sleep, stress, and metabolism: From physiological to pathological conditions
Camila Hirotsu et al.
SLEEP SCIENCE (2015)
Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience
M. V. Fogaca et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
The effects of cannabinoid administration on sleep: a systematic review of human studies
Peter J. Gates et al.
SLEEP MEDICINE REVIEWS (2014)
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal A Randomized Clinical Trial
David J. Allsop et al.
JAMA PSYCHIATRY (2014)
Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings
Celia J. A. Morgan et al.
ADDICTIVE BEHAVIORS (2013)
Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report
J. A. S. Crippa et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2013)
Cannabidiol enhances consolidation of explicit fear extinction in humans
Ravi K. Das et al.
PSYCHOPHARMACOLOGY (2013)
The Role of Life Events and HPA Axis in Anxiety Disorders: A Review
Carlo Faravelli et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
R. Martin-Santos et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Psychobiological responses to unpleasant emotions in cannabis users
Lorenzo Somaini et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2012)
Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats
Yi-Tse Hsiao et al.
NEUROPHARMACOLOGY (2012)
Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug
Alexandre Rafael de Mello Schier et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2012)
Endocannabinoid system dysfunction in mood and related disorders
C. H. Ashton et al.
ACTA PSYCHIATRICA SCANDINAVICA (2011)
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
Ethan B. Russo
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Subjective and Physiological Effects After Controlled Sativex and Oral THC Administration
E. L. Karschner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
Jose Alexandre S. Crippa et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study
Toby T. Winton-Brown et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naive Social Phobia Patients
Mateus M. Bergamaschi et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Cannabis in Sport Anti-Doping Perspective
Marilyn A. Huestis et al.
SPORTS MEDICINE (2011)
Amygdala reactivity is inversely related to level of cannabis use in individuals with comorbid cannabis dependence and major depression
Jack R. Cornelius et al.
ADDICTIVE BEHAVIORS (2010)
Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol A Neural Basis for the Effects of Cannabis sativa on Learning and Psychosis
Sagnik Bhattacharyya et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Distinct Effects of Delta 9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
Paolo Fusar-Poli et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Oxidative stress and anxiety Relationship and cellular pathways
Jaouad Bouayed et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2009)
Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids
Alline Cristina Campos et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
The effects of cannabinoids on serum cortisol and prolactin in humans
Mohini Ranganathan et al.
PSYCHOPHARMACOLOGY (2009)
Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition
Stefan J. Borgwardt et al.
BIOLOGICAL PSYCHIATRY (2008)
The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain
Barbara Costa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids
AB Ilan et al.
BEHAVIOURAL PHARMACOLOGY (2005)
Agonistic properties of cannabidiol at 5-HT1a receptors
EB Russo et al.
NEUROCHEMICAL RESEARCH (2005)
Endocannabinoid system and stress and anxiety responses
MP Viveros et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
The psychobiology of anxiety
J Kim et al.
CLINICAL NEUROSCIENCE RESEARCH (2005)
Effects of cannabidiol (CBD) on regional cerebral blood flow
JAD Crippa et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Effect of Δ-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults
AN Nicholson et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
分享论文
